安進 AMGN 深 滬
交易中 10-07 12:13:22 美东时间
415.16
+12.560
+3.12%
華盛通- 最 高415.79
- 今 開403.06
- 成交量 82.50万股
- 最 低 401.85
- 昨 收 402.60
- 總市值 2244.49亿
- 52周最高 447.03
- 市盈率 靜 29.18
- 換手率 0.15%
- 52周最低 278.06
- 委 比 -22.22%
- 總股本 5.41亿
- 歷史最高 447.03
- 量 比 0.76
- 振 幅 3.46%
- 歷史最低 -33.479
- 每 手 1
- 風險率 38.23%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Morgan Stanley Maintains Equal-Weight on Amgen, Lowers Price Target to $359
Morgan Stanley analyst Terence Flynn maintains Amgen (NASDAQ:AMGN) with a Equal-Weight and lowers the price target from $362 to $359.
10-07 22:22
美股异动 | 医药股逆势活跃，安进升逾3%，吉利德科学升逾2%；部分芯片股低开走高，英特尔、闪迪升约1%
医药股逆势活跃，安进升逾3%，吉利德科学升逾2%，礼来、强生、艾伯维公司升约2%；部分芯片股低开走高，英特尔、闪迪升约1%，英伟达接近转升>>
10-07 22:12
GSK-owned ViiV succeeds in late-stage trial for HIV therapy
ViiV Healthcare, an HIV treatment developer owned by GSK (GSK) with Shionogi (SGIOY) (SGIOF) as an investor, announced on Tuesday that its long-acting HIV treatment Cabenuva succeeded in a late-stage ...
10-07 00:43
Pfizer declares $0.43 dividend
Pfizer (PFE) declares $0.43/share quarterly dividend, in line with previous. Forward yield 6.25% Payable Dec. 7; for shareholders of record Nov. 6; ex-div Nov. 6. See PFE Dividend Scorecard, Yield Cha...
10-06 22:02
AbbVie flags $216M IPR&D and milestones expense for Q3
AbbVie (ABBV) said its Q3 financial results will likely include an acquired in-process research and development (IPR&D) and milestones expense of $216M on a pre-tax basis. As a result, GAAP and non-GA...
10-06 05:04
CSL strikes $1.6B deal with Alentis for experimental kidney, liver drug
CSL (CSLLY) agreed to pay Alentis Therapeutics $355 million upfront as part of a global partnership to develop lixudebart, an experimental antibody being studied for serious kidney and liver diseases....
10-05 06:41
AbbVie, Amgen, Pfizer, GSK among participants in new 340B rebate pilot
The Trump administration has selected 10 companies, including AbbVie (ABBV), Amgen (AMGN), Pfizer (PFE), and GSK (GSK), for a new pilot program that tests a rebate model for drugs purchased under a fe...
10-04 02:37
Amgen’s Evolocumab Study Signals Quiet Efficiency Gains for Cholesterol Franchise
Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s ...
10-03 00:30
Ohio Rep. David Taylor Bought Up to $45K Worth of Amgen Stock
October 1, 2026 records indicate that Representative David Taylor filed a purchase of Amgen (NASDAQ:AMGN), valued between $3,003 and $45,000. According to the October filing, the transaction occurred on September 22, 2026. Currently, Amgen shares are trading down 0.76% at $404.19. Representative's R...
10-02 23:00
Medicare drug pricing model to affect only four firms after Trump’s MFN policy
A new Medicare payment model aimed at lowering prices for drugs administered in doctors’ offices may apply to only four pharmaceutical manufacturers after the industry struck multiple most-favored-nat...
10-02 19:32
